Digital inhalers may help predict occurrence of acute exacerbations of COPD for patients in an ambulatory setting.

Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...

In a major positive step for global respiratory health, Member States at the 78th World Health Assembly (WHA), held May 19–27 ...

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

Inhaler Advantages Portability: Inhalers are small, portable, and easy to carry, making them convenient for on-the-go asthma management. Faster Onset: Inhalers deliver medication quickly to the lungs, ...

Australians living with chronic obstructive pulmonary disease (COPD) are being exposed to greater health risks as the use of a critical diagnostic ...

With greater clinical severity, they recommend adding a long-acting muscarinic receptor antagonists (LAMA) to ICS + long-acting b2 agonist (LABA) combination for 'triple therapy'.

By comparison, both the 3-year TORCH [24] and 4-year UPLIFT [25] COPD trials enrolled adults aged 40 years or more with mean ages of 65 ± 8 and 64.5 ± 8 years, respectively, and excluded ...

Home-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but access is still a challenge. "The science shows that there is greater ...

Miami (June 17, 2025) – Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study. The study is published in the ...

This study describes a synthetic route to access LY104, a structurally novel compound investigated for the treatment of chronic obstructive pulmonary disease (COPD). Our approach to LY104 encompasses ...